CBLL vs JAZZ · rev $65.4M vs P/E 1988, rev $4.07B
CeriBell, Inc (CBLL) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CeriBell, Inc (CBLL) is a medical devices company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CBLL currently screens at market cap $768.1M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CBLL and JAZZ stock pages for the full models.
Not investment advice.